X-Square Capital, LLC

CIK 0001729300 · GUAYNABO, PR · Quarter end: 2026-06-30 · Filed on: 2026-08-12 · Open the SEC source

X-Square Capital, LLC reported 176 positions worth $394.1K as of June 30, 2026 (13F filed August 12, 2026). Largest holding: ASTS (5.7%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$394.1K
2026 Q2
Positions
176
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
34.8%
Est. Net Flow (Q)
2026 Q2
10 / 176 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1ASTSAST SPACE MOBILE INCSH$22.4K5.67%251,520
2AMDADVANCED MICRO DEVICES ISH$21.4K5.44%36,872
3MUMICRON TECHNOLOGYSH$16.2K4.11%14,017
4SPYSPDR S&P 500 ETFSH$15.6K3.96%20,879
5IRENIREN LIMITEDSH$14.8K3.74%322,645
6HIMSHIMS & HERS HEALTH INCSH$14.8K3.74%425,519
7APPAPPLOVIN CORPORATIONSH$11.0K2.79%21,343
8VISTVISTA ENERGY S.A.B DE C.V.SH$8.7K2.22%136,988
9METAMETA PLATFORMS INC CLASS ASH$6.3K1.59%11,098
10SUSUNCOR ENERGY INC FSH$6.2K1.56%114,749

The free plan shows the top 10 positions. The remaining 166 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does X-Square Capital, LLC hold as of Q2 2026?

X-Square Capital, LLC reported 176 positions worth $394.1K in its Q2 2026 13F filing. Largest positions: ASTS (5.7%), AMD (5.4%), MU (4.1%), SPY (4.0%) and IREN (3.7%).

What did X-Square Capital, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did X-Square Capital, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.